Amicus Therapeutics Inc - FOLD - stock price prediction, stock price target, analyst ratings from 12 analysts

Amicus Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of 17.7%, and profit growth estimate of 51.1% for FY25, based on top 12 analyst calls.